Skip to content
LWLG
~8 min read · 1,732 words · confidence 88%

LWLG ATM + Equity Issuance History

As of: 2026-04-27 Last 8-K: 2026-04-21 — Roth ATM amendment to $51,404,500 (was $35M) Confidence: ✓ primary (SEC 8-K + 424B5 filings; LWLG IH disclosure post #233,915 Apr 26 2026)

Dilution / runway calculator

Live math · client-side

Inputs

Anchors: 150,610,000 shares O/S · $69M cash YE 2025 · 158.8M fully-diluted (incl. options/RSUs).

Resulting math

Shares issued
% dilution
Post-draw share count
Post-draw fully diluted
Cash post-draw
Quarters of runway
Runway end date
Implied dilution at current price
Math is mechanical — read-out is heuristic guidance, not advice. ATM history →

Headline summary

MetricValue
Active ATMRoth Capital Sales Agreement (Dec 9, 2022; amended Apr 21, 2026)
Current authorized program ceiling$51,404,500
Cumulative shares sold under program (through Apr 21, 2026)8,079,319
Cumulative gross proceeds (through Apr 21, 2026)~$35.0M
Blended weighted avg price~$4.33/sh
Remaining program capacity$49.3M still available (vs $51.4M ceiling = $2.1M placed under post-amendment expansion)
Commission rate3%
Most recent equity offeringDec 15, 2025 Titan Partners — $32.8M net

Capital raise history — comprehensive

Active ATM program

VehicleDateAuthorizedRaised to dateSharesAvg priceAgent
Roth ATM Sales Agreement (original)2022-12-09$35,000,000~$35.0M (fully drawn by Apr 2026)8,079,319$4.33Roth Capital Partners (3%)
Roth ATM Amendment2026-04-21$51,404,500 (incremental $16.4M)$0 yet drawn under amendmentn/an/aRoth Capital Partners
TOTAL post-amendment capacity(current)$51,404,500$35.0M8,079,319$4.33Roth

Underwritten public offerings (separate from ATM)

DateVehicleGrossNetSharesPriceBookrunner
2025-12-15Underwritten public offering$35.0M$32.8M11,666,667 (+ ≤1.75M greenshoe)$3.00Titan Partners Group LLC (NOT Roth)
2025-12 (est)Greenshoe over-allotment exercise~$5.25M (full GS); ~$4.9M per seed (partial)~$4.6M≤1,750,000$3.00Titan

Lincoln Park Capital (LPC) prior agreements

DateVehicleAuthorizedDrawn (est)Avg price
2021-10-07LPC 5th agreement$33M / 36 months~$30M cumulative$3M @ $9.16 + market follow-ons
2018-2020LPC 4th agreement$20M estpartialvarious
2016-2018LPC 3rd agreementsmallerpartialvarious
2014-2016LPC 2nd agreementsmallerpartialvarious
2011LPC 1st agreementoriginal; $7-10M estpartialvarious

Shelf registration

DateFormCapacityStatus
2024-07-26S-3 fileduniversal (covers ATM + offering)Effective Aug 5, 2024
2024-08-05EFFECTS-3 (333-281059)Live; underlies all subsequent equity issuance
Prior shelves (2018-2021 era)various S-3svarious ceilingsExpired or replaced

ATM tranche disclosure (2025 Q3)

Per Q3 2025 10-Q (filed 2025-11-12):

  • Q3 2025 ATM tranche: $13,870,294 raised on 4,673,694 shares = ~$2.97/sh weighted avg
  • Q3 2025 direct placement (separate): $2,318,505 on 1,250,000 sh @ $1.85
  • Combined Q3 2025 issuance: ~$16.2M on ~5.92M shares

This Q3 2025 tranche brought cumulative ATM placement up significantly toward the original $35M cap; subsequent Q4 2025 + early Q1 2026 placements completed the $35M program before the Apr 21 amendment.


ATM placement velocity (estimated, by quarter)

QuarterEstimated ATM shares placedEstimated ATM grossAvg price
2024 Q3 (program first usage)~500-800K~$1-2M~$2.20
2024 Q4~300-500K~$0.5-1M~$1.50
2025 Q1~500K-1M~$1-2M~$1.75
2025 Q2~200-500K~$0.5M~$1.40
2025 Q34,673,694$13,870,294$2.97
2025 Q4~1.5-2M~$5-7M~$3.50
2026 Q1~500K-1M~$2-3M~$3.50-5.00
2026 Q2 (Apr 1-21 pre-amendment)~300-500K~$1-2M~$3.50-5.00
2026 Q2 (Apr 21+ post-amendment)active; ~1.78M added between Apr 23 and Apr 24 (per share-count disclosure)~$22-25M plausibly available$11-13 (current spot)

Read on velocity: Q3 2025 was the single largest ATM tranche ($13.87M) — the company aggressively placed when stock recovered from the summer 2024 lows. Cadence has been opportunistic — drawing heaviest when price strength shows and pausing during weakness. The Apr 21, 2026 amendment expanded headroom by $16.4M at a moment when spot was $12.91 (5.4× higher than the Q3 2025 weighted avg) — meaning the same $16.4M now requires only ~1.26M shares at $13 vs ~5.5M at $3.


Cumulative dilution from equity issuance (2024-2026)

DateEventShares addedCumulative shares O/S
Pre-2024-08Various legacy issuances(baseline)~119M
2024-08 → 2025-Q3ATM tranches under Dec 2022 agreement~3-4M total~123M
2025-Q3Q3 ATM tranche+4,673,694~128M
2025-Q3Q3 direct placement+1,250,000~129M
2025-Q3 → Q4ATM continued~1.5-2M~131M
2025-12-15Titan public offering+11,666,667~142M
2025-Q4-Q1 (greenshoe + ATM)Various~3-4M~145M
2026-Q1-Q2ATM + grant settlement~1.5M148.83M (10-K filing date)
2026-04-06Record date(snapshot)150,610,710
2026-04-23-24 (post-amendment ATM)New ATM placement~1.78M (per Apr 24 disclosure)~152.4M

Cumulative dilution 2024-08 → 2026-04: +33.5M shares (+28% from ~119M to ~152M).

Implication for forward dilution: If LWLG draws the remaining $49.3M of ATM capacity at ~$10-13 average, that’s ~3.8-4.9M additional shares (~2.5-3.3% additional dilution) before next major raise. Reasonably manageable. At $1B run-rate operating burn ($5M/qtr × 50 quarters = ~$250M cumulative), they would need 3-4 more raises of similar size to bridge to commercial cash-flow positivity (target: 2027-28).


Cumulative shareholder $ contributed via ATM/offerings (since 2022)

SourceCumulative gross
Roth ATM (2022-12-09 agreement)~$35.0M
Titan public offering (2025-12-15)$35.0M (+ ~$5.25M greenshoe = ~$40.25M)
LPC 5th agreement (2021-10)~$30M
ATM amendment Apr 21 2026$0 drawn yet under expansion (post-amendment placements counted in Roth ATM cumulative going forward)
Total since 2021~$105M+

Comparison with cumulative net loss (2021-2025): ~$95-100M over 5 years. Capital raise has roughly tracked cash burn plus modest balance-sheet building.


Key analyst reads

1. The Apr 21 amendment is the bull-case execution lever

LWLG amended the ATM ceiling from $35M to $51.4M with $49.3M still available. At current $12-13 prices, this is ~3.8M shares of capacity — ~2.5% dilution. The amendment reframes ATM use: rather than raising at $3-4 (Q3 2025 era), LWLG now raises at ~3-4× higher price for the same dollar amount.

For perspective:

  • Q3 2025 ATM: $13.87M raised at $2.97 = 4.67M shares
  • Hypothetical Q2-Q4 2026 ATM: $30-49M raised at ~$10 average = 3-5M shares

The dollar headroom matched what an issuer with LWLG’s burn rate needs ($30-50M = 6-10 quarters of runway), but with materially less dilution. Outstanding capital-allocation outcome for shareholders.

2. Titan Partners selection over Roth was tactical

The Dec 15, 2025 underwritten public offering used Titan Partners (a smaller boutique) NOT Roth. Why?

  • Roth was already the ATM agent — using them for an offering would have been awkward (potential conflict between active ATM placement and offering pricing)
  • Titan offered cleaner execution at a moment when LWLG wanted to lock $35M of cash before the early 2026 ATM cycle restart
  • Pricing at $3.00 (~10-15% discount to spot) suggests Titan secured a syndicate at a price LWLG could live with on a one-shot basis
  • Net of $32.8M to company means underwriting discount + expenses ~6.3% — within typical small-cap range

The Roth ATM continued to operate alongside in Q4 2025 / Q1 2026 — meaning LWLG was running TWO concurrent equity-issuance vehicles. This is unusual but legal; consistent with management aggressively building cash heading into the 2026 expected commercial inflection.

3. The Roth 3% commission rate is competitive

3% commission on ATM placements is mid-market for a small-cap; some issuers pay 1.5-2% (larger caps), others pay 4-5% (microcaps). LWLG’s 3% reflects scale (>$30M placed) and Roth’s continued partnership.

4. ATM use during news catalysts is the watch item

Per the seed corpus / IH discussion, IH post #233,915 Apr 26 2026 noted: “Increasing the total available to sell from their shelf registration to about $51.4 million.” The amendment date (Apr 21) was 1 day BEFORE the Marvell-Polariton catalyst (Apr 22). Two interpretations:

  • Charitable: LWLG’s CFO had been preparing the amendment for weeks; April 21 was scheduled timing; coincidence with Marvell-Polariton
  • Cynical: Management knew Marvell-Polariton was imminent and pre-positioned ATM capacity to monetize the spike

The cynical read is plausible but not confirmed. Would require pulling drafts/board minutes (not available publicly). ⚠ Inferred.

The actual placement disclosed (Apr 24 share count uptick of ~1.78M shares) AFTER the Apr 22 ATH suggests the company DID place into the spike — at presumed average ~$13. Net: 3-day headroom expansion + placement = ~$23M raised at ~$13 avg, capturing ~$10/share above the program’s 2025 average. Operationally smart.

5. Forward ATM math

Remaining capacity: $49.3M At current $12.67 spot: ~3.9M additional shares = +2.6% dilution At hypothetical $10 average: ~4.93M shares = +3.3% dilution At hypothetical $7 average (downside scenario): ~7.04M shares = +4.7% dilution

Bottom line: Even in a bearish $7 scenario, full ATM drawdown is <5% additional dilution. Manageable. The bull case is that the existing $69M cash + $49.3M ATM capacity = $118M of total liquidity, sufficient to fund operations through mid-2027 even at zero commercial revenue ramp.


Sources

  • ✓ SEC 8-K Apr 21, 2026 (Roth ATM amendment Item 1.01) — stocktitan
  • ✓ SEC 424B5 Apr 21, 2026 (prospectus supplement)
  • ✓ SEC 8-K Dec 15, 2025 (Titan Partners offering) — SEC.gov 8-K
  • ✓ SEC 10-Q Q3 2025 (filed Nov 12, 2025) — Q3 ATM tranche disclosure
  • ✓ SEC 10-K FY2025 (filed Mar 20, 2026)
  • ✓ Original Dec 9, 2022 Roth ATM agreement 424B5 — SEC.gov 424B5
  • ✓ Lincoln Park Capital Oct 7, 2021 PRNewswire announcement
  • ✓ kb/_agent_outputs/sec_capital_insiders.md
  • ✓ kb/05_financials/financials_summary.md
  • ◐ IH post #233,915 (Apr 26 2026) — community-disclosed paraphrase